Indian Lapatinib Exporters: Complete Supplier Ranking with Market Share — 128 Manufacturers (2026) — TransData Nexus

Q: Who is the largest lapatinib buyer importing from India?

M/S. UPS (UNITED STATES) is the largest lapatinib importer from India with a 12.9% market share and import value of $690.7K.

Q: How many lapatinib buyers import from India?

There are 128 active lapatinib buyers importing from India, with a combined import market of $5.4M across 300 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top lapatinib buyers from India?

The top 5 lapatinib buyers — M/S. UPS, AMINCORP, TOROPH, TOROPH ,, THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS — together control 18.8% of total lapatinib import value from India.

Suresh Sormare

Lapatinib

India Pharmaceutical Trade Intelligence

$5.4M86 Suppliers49 CountriesHS 30049099

ExportsIndia → UNITED STATES54.4%India → UNITED ARAB30.5%

ImportsROMANIA → India$590.4K SWITZERLAND → India$47.8K

#1 Supplier: NATCO PHARMA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $2.9M through 2 shipments. This represents a market share of 54.4% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• M/S. UPS - $690.7K (23.7% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $1.5M, indicating premium pricing strategy compared to the market average of $17.8K.

United States is a key market for Lapatinib imports, representing 54.4% of total trade value.

Primary Market

Secondary Market

2United Arab Emirates

United Arab Emirates emerges as the second largest importing country, achieving a total trade value of $1.6M through 0 shipments. This represents a market share of 30.5% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Lapatinib buyer market intelligence

1Buyer Segment Analysis

The 128 buyers of Lapatinib from India can be categorized into several segments:

1. Distributors: Entities that purchase Lapatinib in bulk to supply to various healthcare providers. For instance, M/S. UPS in the United States, the top buyer with imports totaling $0.69 million, likely operates as a distributor, given the substantial volume imported.

2. Hospital Groups: Large healthcare institutions procuring Lapatinib for patient treatment. While specific hospital groups are not identified among the top buyers, it's common for such entities to source directly from manufacturers or authorized distributors.

3. Retail Chains: Pharmacy chains that stock Lapatinib for prescription fulfillment. The data does not specify retail chains among the top buyers, but they typically procure through distributors.

4. Government Procurement: National health agencies or international organizations purchasing for public health programs. Entities like UNICEF or the Global Fund often engage in such procurement, though they are not listed among the top buyers in this dataset.

5. Re-exporters: Companies importing Lapatinib to re-export to other markets. The United Arab Emirates, accounting for 30.5% of imports, may include re-exporters leveraging the country's strategic trade position.

6. Contract Manufacturers: Firms importing Lapatinib for formulation or packaging before distribution. Specific contract manufacturers are not identified among the top buyers.

Typical buying behaviors vary:

Distributors place large, regular orders to maintain supply chains.

Country-Specific Import Regulations

TransData Nexus Lapatinib buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure Lapatinib complies with FDA regulations, including proper labeling and approval status.

3. Estimated Timeline for Registration: Varies; obtaining FDA approval can take several months to over a year, depending on the completeness of the application and FDA review times.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally duty-free in the U.S.

United Arab Emirates

1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

2. Import Registration Process: Requires certification for all imported pharmaceuticals. The UAE accepts the FDA-issued "Certificate to a Foreign Government" for FDA-regulated products.

3. Estimated Timeline for Registration: Typically 3-6 months, depending on documentation and compliance.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals are often exempt from import duties, but it's advisable to confirm with UAE customs.

Kazakhstan

1. Drug Regulatory Authority: Ministry of Healthcare of the Republic of Kazakhstan.

2. Import Registration Process: Requires registration of pharmaceuticals, including submission of quality, safety, and efficacy data.

3. Estimated Timeline for Registration: Approximately 6-12 months, subject to regulatory review.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals may be subject to import duties; specific rates should be verified with Kazakhstan customs authorities.

Philippines

1. Drug Regulatory Authority: Food and Drug Administration (FDA) Philippines.

Demand Drivers & Market Opportunity

TransData Nexus Lapatinib buyer market intelligence

1Demand Drivers & Market Opportunity

Demand for Lapatinib is primarily driven by the prevalence of HER2-positive breast cancer, for which Lapatinib is an approved treatment. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2020. The inclusion of Lapatinib in national essential medicines lists, guided by the WHO Model List of Essential Medicines, facilitates its procurement through government healthcare programs and international organizations. Tender-based purchasing is common, especially in countries with universal health coverage expansion, ensuring broader access to essential cancer treatments. The presence of 128 buyers across 49 countries indicates a diverse and widespread demand for Lapatinib, reflecting its critical role in oncology treatment protocols.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Lapatinib Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest lapatinib buyer importing from India?

Based on import volume and value, M/S. UPS (UNITED STATES) leads with $690.7K in imports and a 12.9% market share — the highest of any single lapatinib importer. AMINCORP (PHILIPPINES) and TOROPH (KAZAKHSTAN) are the next largest buyers.

QHow many companies buy lapatinib from India?

There are 128 active lapatinib buyers importing from India, with a combined market of $5.4M across 300 shipments to 49 countries. The top 5 buyers hold 18.8% of total import value, while the remaining 123 buyers handle the other 81.2%.

QWhich countries import the most lapatinib from India?

The top importing countries for lapatinib from India are United States (54.4%), United Arab Emirates (30.5%), Kazakhstan (3.2%), Philippines (2.3%), Peru (1.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of lapatinib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

Buyer Segment Analysis

TransData Nexus Lapatinib buyer market intelligence

1Buyer Segment Analysis

The 128 buyers of Lapatinib from India can be categorized into several segments:

3. Retail Chains: Pharmacy chains that stock Lapatinib for prescription fulfillment. The data does not specify retail chains among the top buyers, but they typically procure through distributors.

6. Contract Manufacturers: Firms importing Lapatinib for formulation or packaging before distribution. Specific contract manufacturers are not identified among the top buyers.

Typical buying behaviors vary:

Distributors place large, regular orders to maintain supply chains.

Country-Specific Import Regulations

TransData Nexus Lapatinib buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure Lapatinib complies with FDA regulations, including proper labeling and approval status.

3. Estimated Timeline for Registration: Varies; obtaining FDA approval can take several months to over a year, depending on the completeness of the application and FDA review times.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally duty-free in the U.S.

United Arab Emirates

1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

2. Import Registration Process: Requires certification for all imported pharmaceuticals. The UAE accepts the FDA-issued "Certificate to a Foreign Government" for FDA-regulated products.

3. Estimated Timeline for Registration: Typically 3-6 months, depending on documentation and compliance.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals are often exempt from import duties, but it's advisable to confirm with UAE customs.

Kazakhstan

1. Drug Regulatory Authority: Ministry of Healthcare of the Republic of Kazakhstan.

2. Import Registration Process: Requires registration of pharmaceuticals, including submission of quality, safety, and efficacy data.

3. Estimated Timeline for Registration: Approximately 6-12 months, subject to regulatory review.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals may be subject to import duties; specific rates should be verified with Kazakhstan customs authorities.

Philippines

1. Drug Regulatory Authority: Food and Drug Administration (FDA) Philippines.

Demand Drivers & Market Opportunity

TransData Nexus Lapatinib buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lapatinib

Lapatinib

Who Buys Lapatinib from India — 128 Importers Behind a $5.4M Market

Top Lapatinib Importers — Ranked by Import Value

Top Lapatinib Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Lapatinib — and from which countries?

Lapatinib — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

2United Arab Emirates

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Lapatinib Buyers & Importers

QWho is the largest lapatinib buyer importing from India?

QHow many companies buy lapatinib from India?

QWhich countries import the most lapatinib from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Kazakhstan

4Philippines

5Peru

QWhat is the average import order value for lapatinib from India?

Analysis Methodology